Bhatia, N. ., Kantor, J. ., Green, L. ., Weiss, J. ., Willson, C., Cutler, S., Rieger, J., Glover, D. K., Rumney, P., & Goldenberg, G. (2023). Results from Part 1 Safety Run-in Period of a 2-part, Phase 2, Multicenter, Open-label, Proof-of-Concept Study to Evaluate the Safety, Pharmacokinetics, and Efficacy of VP-315 in Subjects with Basal Cell Carcinoma. SKIN The Journal of Cutaneous Medicine, 7(6), s260. https://doi.org/10.25251/skin.7.supp.260